Summary

Ophthalmic Photocoagulator Market Growth & Trends

The global ophthalmic photocoagulator market size is expected to reach USD 213.2 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.7% from 2021 to 2028. The global influence of COVID-19 on eye health and the rise in the incidence of increasing ocular diseases, such as diabetic retinopathy and age-related macular edema, are the key factors fuelling the market growth.

The growing elderly population and the increasing prevalence of diabetes-related blindness are also projected to fuel the market growth. Various eye diseases are quite frequent in the geriatric population. The National Institute on Aging (NIA) estimated that the elderly population would reach 72 million people by 2030. Diabetic retinopathy has become more common as the diabetic epidemic has spread throughout the world. Individuals' average time spent on a digital screen has risen, resulting in a variety of eye-related pain and disorders.

The growing need for ophthalmic photocoagulator, which is cost-effective, painless, and non-invasive, is expected to drive the market. Major market participants are adopting various methods, such as M&A, cooperation, and partnerships, to maintain competitiveness in the industry. For instance, Quantel Medical has acquired Ellex, which includes the company's laser technology solutions. The WHO is currently working on a package of eye care treatments for a variety of eye disorders, with epidemiology and field professionals providing input. Countries will be able to utilize these tools to help them make decisions about service inclusion, delivery methods, and resource implications.

COVID-19 is expected to negatively impact the market growth. This is due to increasing delay in routine ophthalmic procedures due to the growing risk of infection. Additionally, people suffering from ophthalmic disorders are not opting for diagnostic and treatment options to avoid the visit to medical settings due to the spread of the virus. Hence, this is expected to hinder the market growth.

Ophthalmic Photocoagulator Market Report Highlights

• In terms of application, diabetic retinopathy held the largest share in 2020 and is anticipated to be the fastest-growing segment during the forecast period due to an increase in the cases of diabetes globally

• Based on wavelength, the multicolor scan laser photocoagulator segment is expected to grow at the fastest rate of 5.3% during the forecast period as it allows selection of multiple wavelengths in one versatile machine, making it easier for the surgeons

• By end use, ambulatory surgical centers are expected to exhibit the highest growth rate during the forecast period due to their convenience, proximity, and lower costs to patients and insurers

• Asia Pacific is expected to grow at the highest rate due to the maximum cases of diabetic retinopathy in the region

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. Wavelength
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Wavelength outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Ophthalmic Photocoagulator Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising geriatric population
3.4.1.2. Increasing ophthalmic disorders
3.4.1.3. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. High cost of lasers
3.5. Ophthalmic Photocoagulator Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Ophthalmic Photocoagulator: Application Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Glaucoma
4.1.2. Diabetic Retinopathy
4.1.3. Age-related Macular Degeneration
4.1.4. Macular Edema
4.1.5. Others
4.2. Application Market Share, 2020 & 2028
4.3. Segment Dashboard
4.4. Global Ophthalmic Photocoagulator Market by Application Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Glaucoma
4.5.1.1. Glaucoma market estimates and forecast 2016 to 2028, (USD Million)
4.5.2. Diabetic retinopathy
4.5.2.1. Diabetic retinopathy market estimates and forecast 2016 to 2028, (USD Million)
4.5.3. Age-related macular degeneration
4.5.3.1. Age-related macular degeneration market estimates and forecast 2016 to 2028, (USD Million)
4.5.4. Macular Edema
4.5.4.1. Macular edema market estimates and forecast 2016 to 2028, (USD Million)
4.5.5. Others
4.5.5.1. Others market estimates and forecast 2016 to 2028, (USD Million)
Chapter 5. Ophthalmic Photocoagulator: Wavelength Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Green scan laser photocoagulator
5.1.2. Yellow scan laser photocoagulator
5.1.3. Red scan laser photocoagulator
5.1.4. Multicolor scan laser photocoagulator
5.2. Wavelength Market Share, 2020 & 2028
5.3. Segment Dashboard
5.4. Global Ophthalmic Photocoagulator Market by Wavelength Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Green scan laser photocoagulator
5.5.1.1. Green scan laser photocoagulator market estimates and forecast 2016 to 2028, (USD Million)
5.5.2. Yellow scan laser photocoagulator
5.5.2.1. Yellow scan laser photocoagulator market estimates and forecast 2016 to 2028, (USD Million)
5.5.3. Red scan laser photocoagulator
5.5.3.1. Red scan laser photocoagulator market estimates and forecast 2016 to 2028, (USD Million)
5.5.4. Multicolor scan laser photocoagulator
5.5.4.1. Multicolor scan laser photocoagulator market estimates and forecast 2016 to 2028, (USD Million)
Chapter 6. Ophthalmic Photocoagulator: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Ambulatory surgery centers
6.1.3. Ophthalmology clinics
6.2. End-use Market Share, 2020 & 2028
6.3. Segment Dashboard
6.4. Global Ophthalmic Photocoagulator Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2016 to 2028, (USD million)
6.5.2. Ambulatory surgery centers
6.5.2.1. Ambulatory surgery centers market estimates and forecast 2016 to 2028, (USD Million)
6.5.3. Ophthalmology clinics
6.5.3.1. Ophthalmology clinics market estimates and forecast 2016 to 2028, (USD Million)
Chapter 7. Ophthalmic Photocoagulator Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2020 & 2028
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2028:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2028 (Value)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2016 - 2028 (Value)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2016 - 2028 (Value)
7.8. Europe
7.8.1. U.K.
7.8.1.1. Market estimates and forecast, 2016 - 2028 (Value)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2016 - 2028 (Value)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2016 - 2028 (Value)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2016 - 2028 (Value)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2016 - 2028 (Value)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2016 - 2028 (Value)
7.9.2. China
7.9.2.1. Market estimates and forecast, 2016 - 2028 (Value)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2016 - 2028 (Value)
7.9.4. Thailand
7.9.4.1. Market estimates and forecast, 2016 - 2028 (Value)
7.9.5. South Korea
7.9.5.1. Market estimates and forecast, 2016 - 2028 (Value)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2016 - 2028 (Value)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2016 - 2028 (Value)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2016 - 2028 (Value)
7.10.4. Colombia
7.10.4.1. Market estimates and forecast, 2016 - 2028 (Value)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2016 - 2028 (Value)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2016 - 2028 (Value)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2016 - 2028 (Value)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Leaders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company Market Share/Ranking, by region
8.4.3. Competitive Dashboard Analysis
8.4.3.1. Market Differentiators
8.4.3.2. Synergy Analysis: Major Deals and Strategic Alliances
8.5. Private Companies
8.5.1. List of key emerging companies/technology disruptors/innovators
8.5.2. Funding Outlook
8.5.3. Regional Network Map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.6. Supplier Ranking
8.7. Key company profiled
8.7.1. Lumenis
8.7.1.1. Company overview
8.7.1.2. Financial performance
8.7.1.3. Product benchmarking
8.7.1.4. Strategic initiatives
8.7.2. IRIDEX Corporation
8.7.2.1. Company overview
8.7.2.2. Financial performance
8.7.2.3. Product benchmarking
8.7.2.4. Strategic initiatives
8.7.3. Alcon Inc.
8.7.3.1. Company overview
8.7.3.2. Financial performance
8.7.3.3. Product benchmarking
8.7.3.4. Strategic initiatives
8.7.4. Quantel Medical
8.7.4.1. Company overview
8.7.4.2. Financial performance
8.7.4.3. Product benchmarking
8.7.4.4. Strategic initiatives
8.7.5. NIDEK CO., LTD.
8.7.5.1. Company overview
8.7.5.2. Financial performance
8.7.5.3. Product benchmarking
8.7.5.4. Strategic initiatives
8.7.6. Johnson & Johnson Vision Care, Inc.
8.7.6.1. Company overview
8.7.6.2. Financial performance
8.7.6.3. Product benchmarking
8.7.6.4. Strategic initiatives
8.7.7. TOPCON CORPORATION
8.7.7.1. Company overview
8.7.7.2. Financial performance
8.7.7.3. Product benchmarking
8.7.7.4. Strategic initiatives
8.7.8. Bausch & Lomb Incorporated
8.7.8.1. Company overview
8.7.8.2. Financial performance
8.7.8.3. Product benchmarking
8.7.8.4. Strategic initiatives
8.7.9. Meridian Medical Group
8.7.9.1. Company overview
8.7.9.2. Financial performance
8.7.9.3. Product benchmarking
8.7.9.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America ophthalmic photocoagulator market, by region, 2016 - 2028 (USD Million)
Table 3 North America ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 4 North America ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 5 North America ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 6 U.S. ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 7 U.S. ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 8 U.S. ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 9 Canada ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 10 Canada ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 11 Canada ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 12 Europe ophthalmic photocoagulator market, by region, 2016 - 2028 (USD Million)
Table 13 Europe ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 14 Europe ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 15 Europe ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 16 Germany ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 17 Germany ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 18 Germany ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 19 U.K. ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 20 U.K. ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 21 U.K. ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 22 France ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 23 France ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 24 France ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 25 Italy ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 26 Italy ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 27 Italy ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 28 Spain ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 29 Spain ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 30 Spain ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 31 APAC ophthalmic photocoagulator market, by region, 2016 - 2028 (USD Million)
Table 32 APAC ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 33 APAC ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 34 APAC ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 35 China ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 36 China ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 37 China ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 38 Japan ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 39 Japan ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 40 Japan ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 41 India ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 42 India ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 43 India ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 44 Thailand ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 45 Thailand ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 46 Thailand ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 47 South Korea ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 48 South Korea ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 49 South Korea ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 50 Latin America ophthalmic photocoagulator market, by region, 2016 - 2028 (USD Million)
Table 51 Latin America ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 52 Latin America ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 53 Latin America ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 54 Brazil ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 55 Brazil ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 56 Brazil ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 57 Mexico ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 58 Mexico ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 59 Mexico ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 60 Argentina ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 61 Argentina ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 62 Argentina ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 63 Colombia ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 64 Colombia ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 65 Colombia ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 66 Middle East and Africa ophthalmic photocoagulator market, by region, 2016 - 2028 (USD Million)
Table 67 Middle East and Africa ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 68 Middle East and Africa ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 69 Middle East and Africa ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 70 South Africa ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 71 South Africa ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 72 South Africa ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 73 Saudi Arabia ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 74 Saudi Arabia ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 75 Saudi Arabia ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)
Table 76 UAE ophthalmic photocoagulator market, by application, 2016 - 2028 (USD Million)
Table 77 UAE ophthalmic photocoagulator market, by wavelength, 2016 - 2028 (USD Million)
Table 78 UAE ophthalmic photocoagulator market, by end use, 2016 - 2028 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Ophthalmic Photocoagulator Market: Market Outlook
Fig. 14 Ophthalmic Photocoagulator Market: Competitive Insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Ophthalmic photocoagulator market driver impact
Fig. 20 Ophthalmic photocoagulator market restraint impact
Fig. 21 Ophthalmic photocoagulator market strategic initiatives analysis
Fig. 22 Ophthalmic photocoagulator market: application movement analysis
Fig. 23 Ophthalmic photocoagulator market: application outlook and key takeaways
Fig. 24 Glaucoma market estimates and forecast, 2016 - 2028
Fig. 25 Diabetic retinopathy market estimates and forecast, 2016 - 2028
Fig. 26 Age-related macular degeneration market estimates and forecast, 2016 - 2028
Fig. 27 Macular edema market estimates and forecast, 2016 - 2028
Fig. 28 Others market estimates and forecast, 2016 - 2028
Fig. 29 Ophthalmic photocoagulator market: wavelength movement analysis
Fig. 30 Ophthalmic photocoagulator market: wavelength outlook and key takeaways
Fig. 31 Green scan laser photocoagulator market estimates and forecast, 2016 - 2028
Fig. 32 Yellow scan laser photocoagulator market estimates and forecast, 2016 - 2028
Fig. 33 Red scan laser photocoagulator market estimates and forecast, 2016 - 2028
Fig. 34 Multicolor scan laser photocoagulator market estimates and forecast, 2016 - 2028
Fig. 35 Ophthalmic photocoagulator market: end-use movement analysis
Fig. 36 Ophthalmic photocoagulator market: end-use outlook and key takeaways
Fig. 37 Hospitals market estimates and forecast, 2016 - 2028
Fig. 38 Ambulatory surgery centers market estimates and forecast 2016 - 2028
Fig. 39 Ophthalmology clinics market estimates and forecast, 2016 - 2028
Fig. 40 Global ophthalmic photocoagulator market: regional movement analysis
Fig. 41 Global ophthalmic photocoagulator market: regional outlook and key takeaways
Fig. 42 Global market share and leading players
Fig. 43 North America market share and leading players
Fig. 44 Europe market share and leading players
Fig. 45 Asia Pacific market share and leading players
Fig. 46 Latin America market share and leading players
Fig. 47 Middle East & Africa market share and leading players
Fig. 48 North America: SWOT
Fig. 49 Europe SWOT
Fig. 50 Asia Pacific SWOT
Fig. 51 Latin America SWOT
Fig. 52 MEA SWOT
Fig. 53 North America, by country
Fig. 54 North America
Fig. 55 North America market estimates and forecast, 2016 - 2028
Fig. 56 U.S.
Fig. 57 U.S. market estimates and forecast, 2016 - 2028
Fig. 58 Canada
Fig. 59 Canada market estimates and forecast, 2016 - 2028
Fig. 60 Europe
Fig. 61 Europe. market estimates and forecast, 2016 - 2028
Fig. 62 U.K.
Fig. 63 U.K. market estimates and forecast, 2016 - 2028
Fig. 64 Germany
Fig. 65 Germany market estimates and forecast, 2016 - 2028
Fig. 66 France
Fig. 67 France market estimates and forecast, 2016 - 2028
Fig. 68 Italy
Fig. 69 Italy market estimates and forecast, 2016 - 2028
Fig. 70 Spain
Fig. 71 Spain market estimates and forecast, 2016 - 2028
Fig. 72 Asia Pacific
Fig. 73 Asia Pacific market estimates and forecast, 2016 - 2028
Fig. 74 China
Fig. 75 China market estimates and forecast, 2016 - 2028
Fig. 76 Japan
Fig. 77 Japan market estimates and forecast, 2016 - 2028
Fig. 78 India
Fig. 79 India market estimates and forecast, 2016 - 2028
Fig. 80 Thailand
Fig. 81 Thailand. market estimates and forecast, 2016 - 2028
Fig. 82 South Korea
Fig. 83 South Korea market estimates and forecast, 2016 - 2028
Fig. 84 Latin America
Fig. 85 Latin America market estimates and forecast, 2016 - 2028
Fig. 86 Brazil
Fig. 87 Brazil market estimates and forecast, 2016 - 2028
Fig. 88 Mexico
Fig. 89 Mexico market estimates and forecast, 2016 - 2028
Fig. 90 Argentina
Fig. 91 Argentina market estimates and forecast, 2016 - 2028
Fig. 92 Colombia
Fig. 93 Colombia market estimates and forecast, 2016 - 2028
Fig. 94 Middle East and Africa
Fig. 95 Middle East and Africa. market estimates and forecast, 2016 - 2028
Fig. 96 South Africa
Fig. 97 South Africa market estimates and forecast, 2016 - 2028
Fig. 98 Saudi Arabia
Fig. 99 Saudi Arabia market estimates and forecast, 2016 - 2028
Fig. 100 UAE
Fig. 101 UAE market estimates and forecast, 2016 - 2028
Fig. 102 Participant categorization- ophthalmic photocoagulator market
Fig. 103 Market share of key market players- ophthalmic photocoagulator market